Q
Quince Therapeutics, Inc. (QNCX)
NMS – Real Time Price. Currency in USD
0.94
-0.03 (-3.34%)
At close: Jun 26, 2026, 4:00 PM EDT
0.96
+0.02 (1.63%)
After-hours: Jun 26, 2026, 7:56 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
0.94
-0.03 (-3.34%)
At close: Jun 26, 2026, 4:00 PM EDT
0.96
+0.02 (1.63%)
After-hours: Jun 26, 2026, 7:56 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $18.2M significantly exceed its total debt $406.0K, ensuring strong financial flexibility
Total current assets $25.6M exceed Total current liabilities $8.8M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$7.6M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.92 | 6.05 | 10 | |
| Quick ratio | 2.92 | 5.63 | 10 | |
| Debt to Equity | 0.03 | 0.30 | 9.0 | |
| Debt to Assets | 0.02 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -175K | -322K | -186K | -142K | -146K |
| Operating Income | -50M | -25M | -36M | -50M | -49M |
| Net Income | -52M | -31M | -57M | -84M | -33M |
| EBITDA | -50M | -24M | -36M | -50M | -48M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 86.18 | 5.5 |
| Next quarter | N/A | 82.8 | 5.5 |
| Current year | N/A | N/A | 1.0 |
| Next year | N/A | -410.2 | 1.0 |
| Weighted average score | 3.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 191.01 | 44 | 27.26 | 10 |
| Y/Y | 999 | 338.94 | 213.09 | 21.77 | 10 |
| 3y average | 999 | -29.85 | N/A | -15.31 | 3.3 |
| 5y average | 999 | -12.8 | N/A | -7.99 | 3.3 |
| Weighted average score | 6.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |